The Drug Discovery Services Market is expanding globally as pharmaceutical companies, biotechnology firms, and research organizations increasingly rely on external service providers to support drug development. Regional investments in biotechnology infrastructure, growing R&D expenditure, and demand for specialized research capabilities are creating attractive opportunities for CROs worldwide.

Market Research Future reports that the Drug Discovery Services Market was valued at USD 24.96 billion in 2024 and is projected to grow from USD 28.48 billion in 2025 to USD 106.71 billion by 2035, registering a CAGR of 14.12% over 2025–2035.

North America remains a major center for drug discovery services because of its established pharmaceutical ecosystem, advanced research infrastructure, venture investment, and large concentration of CROs. The updated MRFR analysis estimates that North America accounted for approximately 46.8% of market revenue in 2025.

Europe represents another important regional market. Pharmaceutical research capabilities, biotechnology innovation, and established regulatory frameworks support continued demand for outsourced discovery services. European CROs are increasingly developing specialized capabilities in areas such as biologics, computational drug discovery, and precision medicine.

Asia-Pacific is emerging as one of the most attractive growth markets. China and India are expanding biotechnology infrastructure and contract research capabilities, while pharmaceutical and biotechnology companies increasingly seek cost-effective research solutions. MRFR projects Asia-Pacific to grow at a 12.10% CAGR through 2035.

The regional expansion of CRO capabilities is helping pharmaceutical companies diversify research operations. Service providers are investing in new laboratories, technology platforms, and scientific talent to support international customers.

Another important trend is the development of integrated discovery campuses. Instead of offering isolated services, leading providers increasingly combine computational biology, screening, medicinal chemistry, analytical science, and preclinical research under unified platforms. This can reduce handoff delays and simplify project management for customers.

Future opportunities will also come from AI-enabled research, autonomous laboratories, multi-omics, rare-disease discovery, and advanced therapeutic development. These technologies can expand the range of services that CROs provide while creating new revenue opportunities.

Companies that combine global reach with specialized scientific expertise are likely to remain competitive. As pharmaceutical organizations continue balancing innovation, cost management, and speed-to-market objectives, outsourcing will remain an important component of modern drug development.

Overall, regional capacity expansion and technology adoption are expected to support sustained growth in the global Drug Discovery Services Market through 2035.

Understand industry shifts with well-researched analysis:

Dental Industry Market Volume

Dental Prosthetics Market Forecast

Dental Prosthetics Market Outlook

Dental Prosthetics Market Analysis

Diabetes Drug Market Distribution